Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by keeniinvestoron Apr 12, 2016 11:33am
91 Views
Post# 24756558

RE:RE:This is where ....

RE:RE:This is where .... Well the financing for sure however I have a strange feeling there will be something more to it.  There was more info referenced in the Mch 14th NR than just 50M shares @ 0.10.

1)  non-brokered;
2)  aggressive 5 point action plan in place since Aug '15;
3)  100% control now
4)  financial hardship exemption would help expedite process
5) "the offering may result in a new control person of the company" - interesting add-on in the NR

I also like the fact that they were granted the 58-day extension so quickly and that they were so pre-emptive regarding the MCTO.  Not to mention their collaboration agreement with JTS Health - notice the 5 yr term.

All this in just over a month ... they have been busy.  So, like I said, IMHO more could be announced.  We shall see.
Bullboard Posts